Please ensure Javascript is enabled for purposes of website accessibility Lonza and the next wave of healthcare solutions
de
de
intermediary
intermediary
false
true
Gathering data
Disclaimer Not Available

Lonza and the next wave of healthcare solutions

Lonza and the next wave of healthcare solutions

Walter Scott’s John Rae assesses outsourced drugs manufacturer Lonza’s role in the healthcare ecosystem.

noimage


    Key points:

  • Lonza’s role in the healthcare space is simliar to that of chip manufacturers in the semiconductor supply chain.
  • The company has high customer retention which creates resilient revenues.
  • It is investing heavily to support growth, including building manufacturing capacity in the US.
  • Walter Scott sees several quality healthcare businesses with high degrees of profitability, cash generation and low levels of debt.
     


3305309  Exp:  7 august 2026

VERWANDTE THEMEN
Infrastructure: private vs. publicly listed
Artikel | Aktien

As private infrastructure markets face slower deal activity, elevated interest rates and growing levels of undeployed capital, investors may want to reassess where they seek infrastructure exposure.

Global equity income: built for this market
Artikel | Aktien

Global equity income may merit attention as inflation lingers, valuations stay stretched and investors seek more resilient, less correlated equity exposure.

Resilience is a historical trend
Chart of the Week | Makroökonomisch

The S&P 500’s history shows that despite recessions, wars, inflation, and corrections, the market’s long-term trajectory has remained upward. As the U.S. marks 250 years of resilience, the lesson for investors is clear: wealth is built through patience, discipline and staying invested.

Resilient through uncertainty
Chart of the Week | Makroökonomisch

U.S. policy uncertainty has remained elevated and consumer sentiment has weakened. Even so, the economy has stayed resilient, and because growth has held up better than sentiment and headlines suggest, we continue to forecast 2% U.S. growth in 2026, in line with trend.

Gathering data
Disclaimer Not Available

Dies ist eine Marketingkommunikation